At present, the detection of SERPINC1 gene mutation is a necessary method for the diagnosis of AT III deficiency and the identification of the subtype.[17] After we excluded acquired AT III deficiency, genetic testing should be routinely performed on cases with decreased AT III activity levels. This evidence concerns the gene SERPINC1 and hereditary antithrombin deficiency.